Dublin, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/klpvsp/prefilled ) has announced the addition of the "Prefilled Syringes Market (3rd Edition), 2015 - 2025" report to their offering. Injectable drug delivery systems have traversed a long way from conventional syringes with vials to prefilled syringes, auto-injectors, pen injectors and needle free systems. These modern devices have become preferred devices for parenteral administration of drugs, mainly used for treatment of chronic conditions requiring patients to self-administer medication several times a week. The rising demand has also driven the manufacturers to introduce improvements in technology related to the material of prefilled syringes and lubrication (to reduce leachables and extractables). These developments will aid an increasing number of biologic drugs to reach the market. Additionally, the companies have developed multi-chamber prefilled syringes for use with lyophilised drugs. In our research, we have looked at how these developments and other factors are shaping the market and discussed the factors creating opportunities for various stakeholders in the market. The study focuses on analysing the existing market size and potential future growth of these drug delivery devices across different drug therapeutic classes and regions. The forecast, over the next ten years, has been presented both in terms of volume (number of units) and value (USD billion). It takes into account the likely price variation which will occur as a result of mass adoption and increased competition. Owing to uncertainty surrounding the adoption of prefilled syringes in newer drug classes (which are currently in pipeline); we have also done a multi-variate sensitivity analysis to understand the various market growth scenarios. In an effort to identify existing gaps and future opportunities, we have discussed the leading global prefilled syringe manufacturers in the industry, analysed their product portfolio and the likely future developments driven by these companies. We have put special emphasis and provided details on local manufacturers which are very well positioned to take advantage of the emerging big home consumer markets. In addition, we have profiled some important prefilled syringe component manufacturers as well as manufacturers of self-injection systems that use prefilled syringes as primary drug container. The market forecasts across different segments and regions have been presented till 2025. 2014 is the base year; actual figures have been sourced and analysed from publicly available information. Unless otherwise specified, all figures are presented in USD. Example Highlights: - Over 65 drugs and vaccines are already available in prefilled syringes across different therapeutic classes. In addition, there are several more in clinical pipeline which are being tested in prefilled syringes. - Vaccines and anti-coagulants are examples of well-established applications. The emergence of biologics will be a major growth driver; growth in the long-term will be fuelled by pipeline drugs and the rising adoption in developing markets. - Increasing number of suppliers now provide ready to fill/ sterile prefilled syringes, which make up more than 80% of the prefilled syringes market. The integration of prefilled syringes with advanced delivery systems such as pen and autoinjectors will aid in gaining wider adoption. - Companies are constantly innovating technology for improving the compatibility of syringes with biologics to provide better extractables and leachables profiles. In addition, improved ergonomic designs now offer comfortable administration of drugs. - The market is highly consolidated and is currently dominated by key global players such as Becton Dickinson, Gerresheimer, MGlas AG, SCHOTT and Nuova Ompi. Other companies, which are relatively new entrants (e.g. West Pharmaceutical Services, Unilife, Vetter Pharma and Aguettant), are likely to foster more innovation. Apart from these companies, companies such as Datwyler and Aptar Stelmi are well-known suppliers of various components of prefilled syringes. - The global prefilled syringes market is likely to grow at a compounded annual growth rate (CAGR) of 4.3% between 2014 to 2025.Developed markets of the US and EU currently account for 80% of the market. With increasing adoption in Asia Pacific and rest of the world markets, this domination is likely to gradually decline. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction To Prefilled Syringes 4. Needlestick Injuries 5. Growth Drivers 6. Products Available in Prefilled Syringes 7. Recent Developments and Applications of Prefilled Syringes 8. Manufacturers of Prefilled Syringe 9. PFS Component Manufacturers 10. Global Pen and Auto-Injector Manufacturers 11. SWOT Analysis 12. Leading Regional Markets for Prefilled Syringe Systems, 2015 - 2025 13. Global Prefilled Syringes Market Forecast, 2015 - 2025 14. Interview Transcripts 15. Conclusion 16. Appendix 1: Tabulated Data 17. Appendix 2: List of Companies and Organisations - 3S Bio Inc. - Abbott Laboratories - AbbVie Biotherapeutics - Accord Healthcare Ltd. - Adamis Pharmaceuticals Corporation - AET Biotech - Agila Biotech - Aguettant - Akorn - Al Biosciences Inc. - Alchemia Limited - Alder Pharmaceuticals - Alfamatic - Allergan - Almirall - Amega Biotech - American Nurses Association (ANA) - Amgen - Amphastar Pharmaceuticals - Antares Pharma - Aptar Pharma - Apotex - Arte Corporation - AryoGen - Aspen Group - AstraZeneca - Aurum Pharmaceuticals Ltd. - Avesthagen - AXXO - Bang and Olufsen - Barun Medical - BASF Bioresearch Corporation - Baxter - Bayer Healthcare - BD Rx Inc. - Beacon Pharmaceuticals Ltd. - Becton Dickinson - Bespak - Bharat Serums & Vaccines Ltd - Biocad - BioCND Inc. - Biocon - Bio Farma - Biodel Inc. - Biogen Idec - Biogenomics - Bioject - Bioneer - Bio Sidus SA - Bioviz - Bioxpress Therapeutics - BlauFarmaceutica - Boehringer Ingelheim Pharmaceuticals - Bracco Diagnostics - Bristol-Myers Squibb - BuenderGlas - Cadila Healthcare - Cambridge Antibody Technology (Acquired by AstraZeneca) - Cambridge Consultants - Canyon Pharmaceuticals - CDC (Centers for Disease Control and Prevention) - Celgene - Cellofarm - Celltrion - Chandra Bhagat Pharma - Chon Kun Dang Pharmaceuticals - Chugai Pharmaceutical Co., Ltd. - CinnaGen - Cipla - CNS Therapeutics (acquired by Mallinckrodt) - Coherus Biosciences - Consort Medical Company - Covidien - CP Guojian Pharmaceutical Co. Ltd - Credence Medsystems - Crealta Pharmaceuticals - CSL Biotherapies - Daewoong Pharmaceutical Co., Ltd - Daicel Corporation - Daiichi Sankyo - Daikyo Seiko - DALI Medical Devices - Datwyler - Denka Seiken Co., Ltd. - Dermira, Inc. - Dong-A Pharma - Dr. Lazar Laboratorio - Dr. Reddy's Laboratories - Eisai - Elan Pharmaceuticals - Elcam Medical - Eli Lilly - Emcure - EMD Serono - Enzon Pharma - Epirus Biopharmaceutical - European Agency of Occupational Safety and Health - European Medicines Agency (EMA) - European Medicines Evaluation Agency (EMEA) - Eurofarma - Excelsior Medical - Eyetech Inc. - Farmabion del Ecuador C.A - Ferring Pharmaceuticals - FDA - Finox Biotech AG - Fresenius Kabi - Fujifilm Kyowa Kirin Biologics - Future Injection Technologies - GE Healthcare - Genentech - Gene TechnoScience - GenorBiopharm - Genzyme - Gerresheimer - Gland Pharma - GlaxoSmithKline - Globe Medical Tech - Green Cross - Guerbet - Halozyme Therapeutics - Hanwha Chemical - Harvest Moon Pharma - Haselmeier - Helvoet Pharmaceutical - Hikma Pharmaceuticals PLC - Hoffman-La Roche - Hospira - Huahai - ID Biomedical Corporation of Quebec - Il-Yang Pharm. Co., Ltd - Immunex Corporation - Incepta Pharmaceuticals Ltd. - Infusive Technologies LLC - Injex - Intas Pharma - International Diabetes Federation Atlas - Integrity Bio - Ipsen - ItalFarmaco - Isis Innovation - IVEK Corporation - J&J - J.O. Pharma Co. Ltd. - Janssen Biotech Inc. - Japan Synthetic Rubber - Japanese Ministry of Health, Labour and Welfare (MHLW) - JCR Pharmaceuticals - JMS Co. Ltd. - KAISHA Manufacturers - Kaketsuken [The Chemo-Sero-Therapeutic Research Institute] - Kaleo Inc. - Kendall - Kitasato Daiichi Sankyo Vaccine - Kyowa Hakko Kirin - Leo Pharma - LG Life Sciences - Liebmann Group - Lundbeck - LyoGo - Mallinckrodt - Marathon Pharmaceuticals - Maruishi Pharmaceutical - Medac Pharma - Medeca Pharma - Medex India Pvt. Ltd - MedicalChain International Corporation - Medical Glass - MedImmune - Medimop Medical Projects - MedPro Safety Products - Meiji Deika Pharma - Merck & Co. - Meridian - MGlas AG(acquired by Nipro) - Minapharm Pharmaceuticals - Mitsubishi Tanabe - Mitsui Chemicals - Mochida Pharmaceuticals - Momenta Pharmaceuticals - MorphoSys - MSD K.K. - Mycenax Biotech Inc. - Mylan - Nanogen Biopharmaceuticals - NATCO Pharma - National Medical Products Inc. - Nektar Therapeutics - Neutral Glass & Allied industries - Nippon Organon K.K. - Nipro Corporation - Novartis - Novalek Pharmaceuticals Pvt. Ltd - Novo Nordisk - NPS Pharmaceuticals - Nuova Ompi - Occupational Safety and Health Administration (OSHA) - Office of Combination Products (OCP) - Omnikron Group - Onco Biologics Inc. - Ono Pharmaceuticals - Otsuka Holdings Co. Ltd. - Owen Mumford - PA Consulting - Palatin Technologies - Pan Pharma - Paras Biopharmaceutical - Parenteral Drug Association (PDA) - Pars No Tarkib - PFEnex - Pfizer - Pharmaceutical Research and Manufacturers of America (PhRMA) - Pisa - Plas-Tech Engineering - Polyplastics - Probiomed - ProJect Pharmaceutics - Protalix Biotherapeutics - Protein Sciences Corporation - PT BioFarma - Ranbaxy - Regeneron Pharmaceuticals - Reliance Life Sciences - Revolutions Medical - Rexam Pharma - Rhône Poulenc-Rorer - RheimMinapharm - RoseLabs - SafeShot Technologies - Safety Syringes - Samsung Bioepsis - Sandoz - Sanofi Aventis - Sanofi Pasteur - Schering-Plough - Schott - Sciele Pharma - Serum Institute of India - Shandong Pharmaceutical Glass Co., Ltd. - Shandong Weigao - Shandong Zibo Minkang Pharmaceutical Packing Co., Ltd. - Shanghai Celgen Bio-Pharmaceutical - Shantha Biotech - Shire - SHL Medical - SiO2 Medical Products - Solvay Pharmaceuticals B.V - StadaArzneimittel AG - Stelmi - Stevanato Group - Stiefel (a GSK Company) - Strides - Sun Pharma - Suzuken Co. Ltd. - Swedish Orphan Biovitrum AB - Taisei Kako - Taj Pharmaceuticals - Takeda - Talecris Biotherapeutics - TechnoPharm - Teijin Pharma Ltd. - Terumo Corporation - Teva Pharmaceuticals - The Medical House(Acquired by Consort Medical) - The Medicines Company - The Research Foundation for Microbial Diseases of Osaka University - The Tech Group (acquired by West Pharma) - Ticona - Tip-Top - Tolmar - TriboFilm Research - Triveni Polymers(acquired by Gerresheimer) - Troikaa Pharma - TSH Biopharm Corporation Ltd. - UCB - UNICEF - Unilife Corporation - Unimed Del Peru SA - US Medical Instruments Inc. - USPTO - Valeant Pharmaceutical International - Valeritas - Vedat (acquired by Gerresheimer) - Vetter Pharma - Virchow Biotech Private Ltd. - ViroPro - Watson Pharma - West Pharmaceutical Services, Inc. - WHO - Wyeth - YangZhong Wealth Metal Co., Ltd. - Youlyy Industrial Co., Ltd. - Ypsomed - Zealand Pharma - Zeon Chemicals - Zhejiang Hisun Pharma - Zhejiang Xinkang Pharmaceutical Glass Co. Ltd. - Zogenix - ZydusCadila - ZymoGenetics Inc. For more information visit http://www.researchandmarkets.com/research/klpvsp/prefilled
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Infusions and Injectables , Needles and Syringes
